Shandong Buchang Pharmaceuticals Co., Ltd. (603858.SS) — Stock Score Summary

Shandong Buchang Pharmaceuticals Co., Ltd. (603858.SS) has a MoatMap StockRank of 56/100 based on Quality (56/100), Value (45/100), and Momentum (41/100) factor scores. The current signal is HOLD. Shandong Buchang Pharmaceuticals focuses on traditional Chinese medicine. The business lacks global scalability, has low reinvestment runways, and is highly vulnerable to domestic regulatory pricing pressures and volume-based procurement policies in China.

Shandong Buchang Pharmaceuticals Co., Ltd. develops and manufactures patented Chinese patent medicines (CPMs), focusing on cardiovascular and cerebrovascular treatments. The company possesses a dominant market share in the Chinese cardiovascular CPM market, supported by proprietary formulas like Danhong Injection and a massive academic marketing network. It is a leading specialty pharmaceutical company in China, leveraging traditional medicine heritage combined with modern clinical research.

Key Financial Metrics

Price$2.14
Market Cap$2.3B
P/E (TTM)41.72
Price/Book1.55
Return on Equity2.1%
Return on Invested Capital5.4%
Debt/Equity47.29
Gross Margin60.9%
Operating Margin16.8%
Revenue Growth-7.4%
Dividend Yield2.6%
Free Cash Flow$7M

Shandong Buchang Pharmaceuticals Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Shandong Buchang Pharmaceuticals Co., Ltd.’s (603858.SS) StockRank?
MoatMap’s StockRank for Shandong Buchang Pharmaceuticals Co., Ltd. (603858.SS) is 56/100, with a Hold signal. It is a composite of Quality (56), Value (45), and Momentum (41) factor ranks across MoatMap’s 19,000+ stock universe.
Does Shandong Buchang Pharmaceuticals Co., Ltd. have an economic moat?
Shandong Buchang Pharmaceuticals Co., Ltd. (603858.SS) has a Quality factor score of 56/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Shandong Buchang Pharmaceuticals Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for Shandong Buchang Pharmaceuticals Co., Ltd. (603858.SS) is Hold, based on a StockRank of 56/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Shandong Buchang Pharmaceuticals Co., Ltd. in?
Shandong Buchang Pharmaceuticals Co., Ltd. (603858.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).
Browse all ranked stocks603858.SS deep dive reportAI ChampionsHow we score stocksSense-check another stock